Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

ClinicalTrials.gov ID: NCT03219164

Public ClinicalTrials.gov record NCT03219164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects With Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas Aeruginosa (PA) Infection/Colonization

Study identification

NCT ID
NCT03219164
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
149 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2017
Primary completion
May 26, 2020
Completion
Sep 22, 2021
Last update posted
Jun 13, 2022

2017 – 2021

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of California San Francisco (UCSF) - Benioff Children's Hospital San Francisco California 94158
Children's National Health System Washington D.C. District of Columbia 20010
Johns Hopkins All Children's Hospital Outpatient Care Center St. Petersburg Florida 33701
Ann & Robert H Lurie Childrens Hospital of Chicago Chicago Illinois 60611
Corner Children's Hospital Chicago Illinois 60637
University of Mississippi Medical center Jackson Mississippi 39216
Clinical Research of Charlotte Charlotte North Carolina 28277
Cleveland Clinic Cleveland Ohio 44195
USC Department of Pediatrics/Division of Pediatric Pulmonology Columbia South Carolina 29203
Cook Children's Medical Center Fort Worth Texas 76104
The University of Texas Health Science Center at Tyler Tyler Texas 75708
University of Utah Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03219164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03219164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →